(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one, 95.0%, 100g

2-Deoxy-L-ribose, 98.0%, 1g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 5g

1-METHYL-3-AMINO-4-CYANO-5-METHYLSULFANYLPYRAZOLE, 97.0%, 500mg

6-BROMO-7-FLUORO-1H-INDOLE, 95.0%, 5g

1-(6-Aminopyridin-2-yl)ethan-1-one, 97%, 10g

2,4,8-Trichloroquinazoline, 95.0%, 1g

3,3,3-Trifluoropropanal (contains oligomers), 95.0%, 5g

Flacon à col étroit, 250 ml, GL 25, 4 pièce(s)

1-((3-Bromophenyl)sulfonyl)pyrrolidine, 95.0%, 1g

2-(Aminomethyl)-3-bromophenol hydrochloride, 98%, 100mg

1-(2-Fluoro-5-methylpyridin-3-yl)ethanone, 95+%, 250mg

2-Methyl-3-morpholin-4-yl-benzoic acid, 97.0%, 250mg